About Palliare
Palliare is a company based in Galway (Ireland) founded in 2018. Palliare has raised $8 million across 3 funding rounds from investors including European Union, Western Development Commission and Seroba Lifesciences. Palliare offers products and services including EVA15 Insufflator. Palliare operates in a competitive market with competitors including Mizuho OSI, NDSsi, SIDAM, Oakworks and Shenzhen Leimai Technology, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Series A
Jun 28, 2021
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Palliare
Palliare offers a comprehensive portfolio of products and services, including EVA15 Insufflator.
Delivers hands-free pressure control for laparoscopic and endoscopic surgeries.
People of Palliare
Unlock access to complete
Unlock access to complete
Funding Insights of Palliare
Palliare has successfully raised a total of $8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Palliare
Palliare has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Western Development Commission and Seroba Lifesciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity & debt fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Seroba Lifesciences is focused on life sciences venture capital investments.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Palliare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Palliare
Investment portfolio details for Palliare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Palliare
Detailed financials for Palliare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Palliare Comparisons
Peer comparison for Palliare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Palliare
Palliare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mizuho OSI, NDSsi, SIDAM, Oakworks and Shenzhen Leimai Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical tables and consumables are developed by Mizuho OSI.
|
|
| Locked | Locked | Locked |
Manufacturer of LCD surgical displays, wireless imaging medical devices for operating room
|
|
| Locked | Locked | Locked |
Infusion systems and medical devices for hospitals are manufactured.
|
|
| Locked | Locked | Locked |
Produces ergonomic tables for medical imaging, therapy, spa, and massage applications.
|
|
| Locked | Locked | Locked |
Photodynamic therapy equipment is developed for cancer diagnosis and treatment.
|
Detailed competitors of Palliare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Palliare
Complete news archive for Palliare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Palliare
Palliare was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Palliare is headquartered in Galway, Ireland.
Palliare is a funded company, having raised a total of $8M across 3 funding rounds to date.
Palliare was founded in 2018 in Galway, Ireland, within the medical device sector. Surgical smoke evacuation systems are produced to address chemicals, substances, and carcinogens in operating rooms. The EVA Insufflator, a pedal-activated endoscopic device, employs a two-stage charcoal filter for removal of surgical smoke. Connection to operating room scavenging systems is facilitated for integration. Operations focus on filtration technology for endoscopic procedures.
Palliare's top competitors include Mizuho OSI, NDSsi and MezLight.
Palliare offers EVA15 Insufflator.
Palliare has 3 investors. Key investors include European Union, Western Development Commission, and Seroba Lifesciences.